glp-1 active Medications for Weight Loss and Pain Relief Glucagon-like Peptide-1 (GLP-1), Active Form
Description
The most pronounced differences were observed in gastrointestinal and metabolic events: nausea (combination: n = 9651 vs monotherapy: n = 38,030), vomiting (4383 vs 17,062), pancreatitis (1389 vs 6655), and hypoglycemia (773 vs 1778)

If you have diabetes, continue all prescribed medications and monitoring protocols

Do not double dose if missed

ACS Omega

doi: 10.1111/dom.16398

What are the side effects of unapproved GLP-1s